Type 3 diabetes has been interpreted by some researchers to describe the concept that impaired insulin and insulin-like growth factor (IGF) signaling in the brain, similar to what happens in type 2 diabetes, may play a significant role in the development of AD [81,82]. This evidence concerns the gene IGF1 and Alzheimer disease.